Companies in the Psychedelic therapy industry
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
Amicus Therapuetics is a biotechnology company developing therapies to cure rare diseases. | ||||||
Ichor Therapeutics is a pre-clinical contract research on aging mechanisms company founded in 2013 by Kelsey Moody. | ||||||
German life sciences company focused on psychedelic therapies for mental health conditions. | ||||||
Toronto-based company developing drugs for use in psychedelic therapy protocols. | ||||||
COMPASS Pathways is a life sciences company founded in 2016, based in London, UK, that develops clinical research programs and treatments for depression and works to accelerate patient access to evidence-based innovations in mental health. | ||||||
A biotechnology holding company, investing and accelerating portfolio companies engaged in psilocybin, plant sciences, and regulated psychoactive compounds. | ||||||
Developer of arketamine therapy intended to provide effective treatment solutions to serious psychiatric disorders.The company's lead product is the NMDA antagonist arketamine with the potential for rapid acting antidepressant activity and anti-suicidal effects. | ||||||
A biopharmaceutical company using artificial intelligence and computational biophysics to discovery new medicines based on psychedelics. | ||||||
A growing network of psychiatry clinics and research sites specialized in psychedelic medicine. $NM $NM.ca $NVMDF | ||||||
Delix Therapeutics is a CNS-focused drug discovery company. | ||||||
Mydecine Innovations Group is a biotechnology company developing innovative first- and second-generation novel therapeutics for the treatment of mental health and addiction through world-class technology and drug development infrastructure. | ||||||
(Braxia Scientific) Focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine. | ||||||
Psychedelic therapy company applying ketamine and other drugs to treat psychiatric conditions | ||||||
Bright Minds Biosciences is a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. | ||||||
Beckley Psytech is a psychedelic Compounds founded in 2019 by Lady Amanda Feilding. | ||||||
Platform for legal, research-based psychedelic wellness, focusing on education and stewardship. | ||||||
Mushroom life sciences company focused on psychedelic medicines and nutraceutical products. | ||||||
Synthetic biology company developing cannabinoid and psilocybin derivatives. | ||||||
Silo Wellness is a vertically-integrated psychedelic therapy company based in Oregon founded in 2018 by Mike Arnold. | ||||||
Therapsil is a non-profit coalition of professionals dedicated to providing access to Psilocybin Therapy for Canadians with a palliative diagnosis. | ||||||
Gilgamesh Pharmaceuticals is a pharmaceutical platform company developing an oral arylcyclohexylamine therapeutic and the next generation of psychedelic-related medicines. | ||||||
Wesana Health Holdings Inc is an emerging life sciences company championing the development and delivery of psychedelic and naturally-sourced therapies to treat traumatic brain injury. It is developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological and mental health ailments caused by trauma. | ||||||
Entheon Biomedical is a pharmaceutical firm developing secure, legal methods for patients to access evidence-based opioid therapies and patented entheogen-based formulations. | ||||||
London-based company developing anti-inflammatory treatments for Alzheimer's and other conditions using psychedelic compounds like LSD and peyote. | ||||||
Cedar Psychiatry is a specialized provider of ketamine-assisted psychotherapy services founded in 2016 by Reid Robison. |
